Medication info
Newcoposizone 5/160 mg

Newcoposizone 5/160 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
SaeHan Pharmaceutical Co., Ltd.
Appearance
Dark yellow rectangular film-coated tablets
Packaging
For domestic use - 30 tablets/bottle
Approval status
Active

MFDS item code 202000769 · Approved 2020.02.10 · Insurance code 651300940

Summary

Main use
Treatment of essential hypertension not controlled by monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take this medication at the same time each day (e.g., in the morning), if possible. Before administering this medication, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medication to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.
Child dose
Pediatrics: Administration of this medication is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
SaeHan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by monotherapy

  • Essential hypertension
View approved original text

This medicine can be effectively used to manage blood pressure for patients with essential hypertension who do not achieve sufficient blood pressure control with monotherapy of amlodipine or valsartan.

How to take

Adult dose

The recommended dose of this medication is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take this medication at the same time each day (e.g., in the morning), if possible. Before administering this medication, it is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, do not administer this medication to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild to moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years and older: Use caution when increasing the dose.

Child dose

Pediatrics: Administration of this medication is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimester of pregnancy, so it's important to stop taking it immediately if pregnancy is confirmed. Patients with allergies to any components of this medicine, pregnant or nursing women, patients with severe kidney or liver disease, and those with certain heart conditions should not take this medicine. Patients with low sodium or fluid levels in their body may be at risk for low blood pressure, so it's crucial to check their condition carefully before taking this medication and to monitor blood pressure closely while taking it. Patients with high potassium levels or those using medications that can increase potassium should have their blood potassium levels frequently tested. Patients with impaired kidney function or kidney transplant recipients should use this medication cautiously as it may worsen kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue occur while taking this medicine, it should be stopped immediately and medical advice should be sought. Patients with heart failure or myocardial infarction should monitor kidney function and blood pressure closely while taking this medicine, and those with acute myocardial infarction should observe symptoms carefully during the initial period of taking this medication. Patients with reduced liver function should have their dosage limited, and any signs of liver dysfunction should be reported to healthcare providers. Dizziness or fatigue may occur while taking this medicine, so caution is needed when driving or operating machinery. When taking other medications, there may be changes in effectiveness or increased risk of side effects due to interactions, so patients must inform their healthcare providers of all medications they are taking. Women who are pregnant or planning to become pregnant should not use this medicine, and nursing mothers are also advised to avoid it as much as possible. The safety and efficacy of this medicine have not been sufficiently established for children under 18 years of age; therefore, its use is not recommended. The elderly can take similar doses as general adults, but should follow the guidance of healthcare providers based on their condition. In case of overdose, severe low blood pressure or heart problems may occur, so immediate medical attention should be sought for appropriate treatment.

Side effects

nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, oropharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbances, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturnal enuresis, gynecomastia, pain, fatigue, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurogenic sensitivity, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine may be sensitive to air or moisture, so it should be stored in a tightly closed container. Additionally, to maintain the efficacy of the drug, it should be stored at room temperature, between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Dark yellow rectangular film-coated tablets

Package unit

For domestic use - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.